197 related articles for article (PubMed ID: 9755274)
21. Bisphosphonates: biological response modifiers in breast cancer.
Paterson AH
Clin Breast Cancer; 2002 Aug; 3(3):206-16; discussion 217-8. PubMed ID: 12196279
[TBL] [Abstract][Full Text] [Related]
22. Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate.
Cagle AP; Waguespack SG; Buckingham BA; Shankar RR; Dimeglio LA
Pediatrics; 2004 Oct; 114(4):1091-5. PubMed ID: 15466114
[TBL] [Abstract][Full Text] [Related]
23. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
Sekine M; Takami H
Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
[TBL] [Abstract][Full Text] [Related]
24. Safety of pamidronate in patients with renal failure and hypercalcemia.
Machado CE; Flombaum CD
Clin Nephrol; 1996 Mar; 45(3):175-9. PubMed ID: 8706358
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D intoxication and hypercalcaemia in an infant treated with pamidronate infusions.
Ezgu FS; Buyan N; Gündüz M; Tümer L; Okur I; Hasanoglu A
Eur J Pediatr; 2004 Mar; 163(3):163-5. PubMed ID: 14714183
[TBL] [Abstract][Full Text] [Related]
26. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
Jansson S; Tisell LE; Lindstedt G; Lundberg PA
Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
[TBL] [Abstract][Full Text] [Related]
27. Immobilization-related hypercalcaemia--a possible novel mechanism and response to pamidronate.
Gallacher SJ; Ralston SH; Dryburgh FJ; Logue FC; Allam BF; Boyce BF; Boyle IT
Postgrad Med J; 1990 Nov; 66(781):918-22. PubMed ID: 2267202
[TBL] [Abstract][Full Text] [Related]
28. [Immobilization hypercalcemia as a complication of polyneuropathy].
Riehl J; Brandenburg VM; Dietrich CG; Block F
Nervenarzt; 2000 Aug; 71(8):655-9. PubMed ID: 10996916
[TBL] [Abstract][Full Text] [Related]
29. Reversal of hypercalcemic acute kidney injury by treatment with intravenous bisphosphonates.
Auron A; Tal L; Srivastava T; Alon US
Pediatr Nephrol; 2009 Mar; 24(3):613-7. PubMed ID: 18839218
[TBL] [Abstract][Full Text] [Related]
30. The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication.
Lee DC; Lee GY
J Toxicol Clin Toxicol; 1998; 36(7):719-21. PubMed ID: 9865241
[TBL] [Abstract][Full Text] [Related]
31. The rapid correction of hypercalcemia at presentation of acute lymphoblastic leukemia using high-dose methylprednisolone.
Unal S; Durmaz E; Erkoçoğlu M; Bayrakçi B; Bircan O; Alikaşifoğlu A; Cetin M
Turk J Pediatr; 2008; 50(2):171-5. PubMed ID: 18664083
[TBL] [Abstract][Full Text] [Related]
32. Severe Hypercalcemia in a Child With Acute Lymphoblastic Leukemia Relapse: Successful Management With Combination of Calcitonin and Bisphosphonate.
Tagiyev A; Demirbilek H; Tavil B; Buyukyilmaz G; Gumruk F; Cetin M
J Pediatr Hematol Oncol; 2016 Apr; 38(3):232-4. PubMed ID: 26907650
[TBL] [Abstract][Full Text] [Related]
33. Aminohydroxypropylidene bisphosphonate (AHPrBP) treatment of severe immobilization hypercalcaemia in a young patient.
Varache N; Audran M; Clochon P; Lortholary A; Bouachour G; Alquier P; Basle MF
Clin Rheumatol; 1991 Sep; 10(3):328-32. PubMed ID: 1790647
[TBL] [Abstract][Full Text] [Related]
34. Pamidronate-induced irreversible symptomatic hypocalcemia in a dog with hypercalcemia after glucocorticoid withdrawal: a case report.
Oh YI; An JH; Lim GH; Park SM; Kim TH; Seo KW; Youn HY
BMC Vet Res; 2024 May; 20(1):227. PubMed ID: 38790012
[TBL] [Abstract][Full Text] [Related]
35. Tumor 'flare' hypercalcemia--an additional indication for bisphosphonates?
Nikolic-Tomasević Z; Jelic S; Popov I; Radosavljević D; Mitrović L
Oncology; 2001; 60(2):123-6. PubMed ID: 11244326
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of hypercalcemia of malignancy with pamidronate in a patient with advanced recurrent oral cancer].
Nishimura N; Matsushita Y; Takaoka K; Hashitani S; Noguchi K; Urade M
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2537-9. PubMed ID: 12506478
[TBL] [Abstract][Full Text] [Related]
37. Bones, groans and blasts.
Shanks D; Linke R; Saxon B
J Paediatr Child Health; 2001 Oct; 37(5):504-6. PubMed ID: 11885718
[TBL] [Abstract][Full Text] [Related]
38. Hypercalcemia and osteolytic lesions as presenting symptoms of acute lymphoblastic leukemia in childhood. The use of zoledronic acid and review of the literature.
Kolyva S; Efthymiadou A; Gkentzi D; Karana-Ginopoulou A; Varvarigou A
J Pediatr Endocrinol Metab; 2014 Mar; 27(3-4):349-54. PubMed ID: 23934636
[TBL] [Abstract][Full Text] [Related]
39. Bisphosphonate Versus Bisphosphonate and Calcitonin for the Treatment of Moderate to Severe Hypercalcemia of Malignancy.
Khan AA; Gurnani PK; Peksa GD; Whittier WL; DeMott JM
Ann Pharmacother; 2021 Mar; 55(3):277-285. PubMed ID: 32885992
[TBL] [Abstract][Full Text] [Related]
40. [The efficacy and safety of intravenous bisphosphonates in the treatment of primary hyperparathyroidism complicated by hypercalcemia crisis].
Han GY; Wang O; Xing XP; Meng XW; Lian XL; Guan H; Ye W; Xia WB; Li M; Jiang Y; Hu YY; Liu HC; Cui QC
Zhonghua Nei Ke Za Zhi; 2009 Sep; 48(9):729-33. PubMed ID: 20079207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
